Yumanity Therapeutics Inc (NASDAQ:YMTX)
| 11.75 Delayed Data As of Jun 24 |  +0.15 / +1.30%Today’s Change | 11.01 Today|||52-Week Range 36.80 | -30.88% Year-to-Date |
Latest YMTX News | Press Releases
No recent news for Yumanity Therapeutics Inc.
Today’s Trading
| Previous close | 11.54 |
| Today’s open | 11.72 |
| Day’s range | 11.56 - 12.19 |
| Volume | 64,957 |
| Average volume (3 months) | 79,543 |
| Market cap | $124.4M |
Data as of 3:57pm ET, 06/24/2021
Growth & Valuation
| Earnings growth (last year) | +6.70% |
| Earnings growth (this year) | +82.26% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +37.92% |
| P/E ratio | NM |
| Price/Sales | 5.80 |
| Price/Book | 2.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IFRXInflarx NV | -0.02 | -0.67% |
| INMBINmune Bio Inc | +0.39 | +2.06% |
| EQEquillium Inc | +0.02 | +0.33% |
| CALACalithera Bioscience... | +0.07 | +3.40% |
Data as of 3:59pm ET, 06/24/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | -$0.84 |
| Annual revenue (last year) | $6.9M |
| Annual profit (last year) | -$50.8M |
| Net profit margin | -736.51% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
